Skip to main content

Table 2 VTE prophylaxis/treatment of the included patients

From: A cross-sectional, multicenter, observational study to assess the prophylaxis of venous thromboembolism in Lebanese and Jordanian hospitals

Variables

Patients (N = 704)

No. of patients received prophylaxis, No. (%)

415 (58.9)

 - Pharmacological anticoagulant prophylaxis

371 (52.7)

 - Mechanical prophylaxis

13 (1.8)

 - Pharmacological and Mechanical prophylaxis

31 (4.4)

Types of anticoagulant, No. (%)

 - LMWH

366 (51.9)

 - Unfractionated Heparin

56 (7.9)

Timing of anticoagulants for surgical patients, No. (%)

 - Preoperatively

138 (59.23)

 - Postoperatively

94 (40.34)

 - Preoperatively/ Postoperatively

1 (0.43)

No. of patients continued prophylaxis after discharge, No. (%)

128 (30.84)

Duration of LMWH after discharge, mean (SD)

17.58 (80.9)

Duration of Warfarin after discharge, mean (SD)

28 (16.2)

Concomitant treatment No. (%)

460 (65.34)

  1. LMWH Low molecular weight heparin, SD Standard deviation